Omnicare, Inc. has a market cap of $3.55 billion; its shares were traded at around $30.32 with a P/E ratio of 12.9 and P/S ratio of 0.6. The dividend yield of Omnicare, Inc. stocks is 0.9%.
This is the annual revenues and earnings per share of OCR over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of OCR.
Highlight of Business Operations:Net sales for the three and six months ended June 30, 2012 were positively impacted by drug price inflation and growth in SCG. Partially offsetting these factors was the unfavorable sales impact of reductions in reimbursement coupled with competitive pricing issues, the increased availability and utilization of generic drugs and a lower average number of beds served. See discussion of sales and operating income results in more detail at the “Long-Term Care Group Segment” and “Specialty Care Group Segment” captions below.
Gross profit as a percentage of total net sales was 23.9% and 23.5% in the three and six months ended June 30, 2012, versus 21.6% and 21.8%, respectively, in the comparable prior year periods. Gross profit was favorably affected by the increased availability and utilization of higher margin generic drugs, the favorable dollar effect of drug price inflation, growth in the SCG segment, as well as cost reduction and productivity improvement initiatives. Partially offsetting these factors was certain of the aforementioned items that, individually, served to reduce net sales, primarily the reductions in reimbursement coupled with competitive pricing issues as well as by increased payroll and employee benefit costs in connection with the Company s initiatives to improve its organizational structure.
Omnicare s consolidated selling, general and administrative (“operating”) expenses as a percentage of net sales amounted to 13.1% and 12.8% in the three and six months ended June 30, 2012 versus 12.4% and 12.4% , respectively, in the comparable prior-year periods. Operating expenses were unfavorably impacted by the increased payroll and employee benefit costs as well as other costs associated with Omnicare's initiatives to improve its organizational structure and customer service. Partially offsetting these factors was the continued progress in the Company s non-drug purchasing program.
Read the The complete Report